Unraveling distinct intracellular signals that promote survival and proliferation: Study of erythropoietin, stem cell factor, and constitutive signaling in leukemic cells

Journal of Hematotherapy and Stem Cell Research

Volumn 9, Issue 1, 2000, Pages 21-29

  Sawyer, Stephen T ^a   Jacobs Helber, Sarah M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL X; STAT PROTEIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; CELL SURVIVAL; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; HUMANS; LEUKEMIA; SIGNAL TRANSDUCTION; STEM CELL FACTOR;

EID: 0034016974     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581600319586     Document Type: Review

References (66)

1. Koury MJ, and MC Bondurant. (1992). The molecular mechanism of erythropoietin action. Eur J Biochem 210:649-663.
2. Krantz SB. (1991). Erythropoietin. Blood 77:419-434.
3. Sawyer ST, and K Penta. (1994). Erythropoietin cell biology. Hematol Oncol Clin North Am 8:895-911.
4. D'Andrea AD, HF Lodish and GG Wong. (1989). Expression cloning of the murine erythropoietin receptor. Cell 57:277-285.
5. Ihle J. (1995). Cytokine receptor signaling. Nature 377: 591-594.
6. Darnell J. (1996). The Jak-Stat pathway: summary of initial studies and recent advances. Rec Prog Horm Res 51:391-404.
7. Witthuhn B, F Quelle, O Silvennoinen, T Yi, B Tang, O Miyra and J Ihle. (1993). Jak2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-232.
8. Miura O, N Makamura, FW Quelle, BA Witthuhn, JN Ihle and N Aoki. (1994). Erythropoietin induces the association of Jak2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood 84:1501-1507.
9. Sawyer ST, and K Penta. (1996). Association of Jak2 and StatS with erythropoietin receptors. J Biol Chem 271: 32430-32436.
10. Penta K, and ST Sawyer. (1995). Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of Stat1 and Stat5 in erythroid cells. J Biol Chem 270:31282-31287.
11. Gouilleux F, C Pallard, I Dusanter-Fourt, H Wakao, L Haldosen, G Horstedt, D Levy and B Groner. (1995). Prolactin, growth hormone, erythropoietin, and GM-CSF induce MGF-Stat5 DNA-binding activity. EMBO J 14:2005-2010.
12. Pallard C, F Gouilleux, M Charon, B Groner, S Gisselbrecht and I Dusanter-Fourt. (1995). Interleukin-3, erythropoietin, and prolactin activate a Stat5-like factor in lymphoid cells. J Biol Chem. 270:15942-15948.
13. Damen J, and G Krystal. (1996). Early events in erythropoietin signaling. Exp Hematol 24:1455-1460.
14. Miura O, N Nakamura, JN Ihle and N Aoki. (1994). Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. J Biol Chem 269:614-620.
15. Klingmuller U, U Lorenz, L Cantley, B Neel and H Lodish. (1995). Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signals. Cell 80:729-738.
16. Tauchi T, G Feng, R Shen, M Hostlin, G Bagby, D Kabat, L Lu and H Broxmeyer. (1995). Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J Biol Chem 270: 5631-5635.
17. Taniguchi T. (1995). Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251-255.
18. Miura O, Y Miura, N Nakamura, FW Quelle, BA Witthuhn, JN Ihle and N Aoki. (1994). Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood 84:4135-4141.
19. Machide M, H Mano and K Todokoro. (1995). Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain. Oncogene 11:619-625.
20. Parganas E, D Wang, D Stravopodis, DJ Topham, JC Marine, S Teglund, EF Vanin, S Bodner, OR Colamonici, JM van Deursen, G Grosveld and JN Ihle. (1998). Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93:385-395.
21. Korsmeyer SJ. (1999). Bcl-2 gene family and the regulation of programmed cell death. Cancer Res 59:1693-1700.
22. Wu H, X Liu, R Jaenish and H Lodish. (1995). Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59-65.
23. Wu H, U Klingmuller, P Besmer and H Lodish. (1995). Interaction of the erythropoietin and stem cell factor receptors. Nature 377:242-246.
24. Jacobs-Helber SM, K Penta, Z Sun, A Lawson and ST Sawyer. (1997). Distinct signaling from stem cell factor and erythropoietin. J Biol Chem 272:6850-6853.
25. Lawson AE, H Bao, S Jacobs-Helber and ST Sawyer. (1998). Proliferative and antiapoptotic signals are separate in EPO-dependent HCD57 cells. Blood 92 (Suppl 1):Abstract 269.
26. Finucane DM, E Bossy-Wetzel, NJ Waterhouse, TG Cotter and DR Green. (1999). Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-XL. J Biol Chem 274: 2225-2233.
27. Hu Y, MA Benedict, D Wu, N Inohara and G Nunez. (1998). Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 95:4386-4391.
28. Lacronique V, P Varlet, P Mayeux, A Porteu, S Gisselbrecht, A Kahn and C Lacombe. (1997). Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors. Blood 90:3050-3056.
29. Silva M, D Grillot, A Benito, C Richard, G Nunez and JL Fernandez-Luna. (1996). Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through BclXL and Bcl-2. Blood 88:1576-1582.
30. Jacobs-Helber SM, A Wickrema, MJ Birrer and ST Sawyer. (1998). API regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells. Mol Cell Biol 89:3699-3707.
31. Gregoli PA, and MC Bondurant. (1997). The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. Blood 90:630-640.
32. Motoyama N, F Wang, KA Roth, H Sawa, K Nakayama, I Negishi, S Senju, Q Zhang and S Fujii. (1995). Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506-1510.
33. Lacronique V, P Varlet, P Mayeux, A Porteu, S Gisselbrecht, A Kahn and C Lacombe. (1997). Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors. Blood 90:3050-3056.
34. -/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98:181-191.
35. Silva M, A Benito, C Sanz, F Prosper, D Ekhterae, G Nunez and JL Fernandez-Luna. (1999). Erythropoietin can induce the expression of Bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J Biol Chem 274:22165-22169.
36. Damen J, H Wakao, A Miyajima, T Krosl, R Humphries, R Cutler and G Krystal. (1995). Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J 14:5557-5562.
37. Bao H, SM Jacobs-Helber, AE Lawson, K Penta, A Wickrema and ST Sawyer. (1999). Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and Stat5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood 93:3757-3773.
38. Liu X, G Robinson, K Wagner, L Garrett, A Wynshaw-Boris and L Hennighausen. (1997). Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11:179-185.
39. Teglund S, C McKay, E Schuetz, JM van Deursen, D Stravopodis, D Wang, M Brown, S Bodner, G Grosveld and JN Ihle. (1998). Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841-850.
40. Gregory T, C Yu, A Ma, SH Orkin, GA Blobel and MJ Weiss. (1999). GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating Bcl-XL expression. Blood 94:87-96.
41. Gouilleux-Gruart V, F Gouilleux, C Desaint, J Claisse, J Capiod, J Delobel, R Weber-Nordt, I Dusanter-Fourt, F Dreyfus, B Groner and L Prin. (1996). Stat-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87: 1692-1698.
42. Weber-Nordt R, C Egen, J Wehinger, W Ludwig, V Gouilleux-Gruart, R Merteismann and J Finke. (1996). Constitutive activation of Stat proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88:809-814.
43. Sartor C, M Dziubinski, C Yu, R Jove and S Ethier. (1997). Role of epidermal growth factor receptor and Stat-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res 57:978-986.
44. Watson C, and W Miller. (1995). Elevated levels of members of the Stat family of transcription factors in breast carcinoma nuclear extracts. Br J Cancer 71:840-846.
45. Zhang Q, I Nowak, E Vonderheid, A Rook, M Kadin, P Nowell, L Shaw and M Wasik. (1996). Activation of Jak/Stat proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci USA 93:9148-9153.
46. Danial N, A Pernis and P Rothman. (1995). Jak-Stat signaling induced by the v-abl oncogene. Science 269:1875-1890.
47. Ohashi T, M Masuda and S Ruscetti. (1995). Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus. Blood 85:1454-1461.
48. Migone T, J Lin, A Cereseto, J Mulloy, J O'Shea, G Franchini and FW Leonard. (1995). Constitutively activated Jak-Stat pathway in T cells transformed with HTLV-I. Science 269:79-83.
49. Campbell G, C Yu, R Jove and C Carter-Su. (1997). Constitutive activation of Jak1 in Src-transformed cells. J Biol Chem 272:2591-2599.
50. Nielsen M, K Kaltoft, M Nordahl, C Ropke, C Geisler, T Mustelin, P Dobson, A Svejgaard and N Dum. (1997). Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tryphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci USA 94:6764-6769.
51. Carlesso N, D Frank and J Griffin. (1996). Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (Stat) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 183:811-816.
52. Zha J, H Harada, E Yang, J Jockel and SJ Korsmeyer. (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not Bcl-X. Cell 87:619-628.
53. Blume-Jensen P, R Janknecht and T Hunter. (1998). The kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of BAD on Serl36. Curr Biol 8:779-782.
54. Franke TF, and LF Cantley. (1997). Apoptosis. A BAD kinase makes good. Nature 390:116-117.
55. Harada H, B Becknell, M Wilm, M Mann, LJ Huang, SS Taylor, JD Scott and SJ Korsmeyer. (1999). Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol Cell 3:413-422.
56. Scheid MP, and V Duronio. (1998). Dissociation of cytokine-induced phosphorylation of BAD and activation of PKB/akt: involvement of MEK upstream of BAD phosphorylation. Proc Natl Acad Sci USA 95:7439-7444.
57. Majewski M, M Nieborowska-Skorska, P Salomoni, A Slupianek, K Reiss, R Trotta, B Calabretta and T Skorski. (1999). Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. Cancer Res 59:2815-2819.
58. Wang HG, and JC Reed. (1998). Bcl-2, Raf-1 and mitochondrial regulation of apoptosis. Biofactors 8:13-16.
59. Bi L, I Okabe, DJ Bernard, A Wynshaw-Boris and RL Nussbaum. (1999). Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110a1-pha subunit of phosphoinositide 3-kinase. J Biol Chem 274: 10963-10968.
60. Klingmüller U, H Wu, JG Hsiao, A Toker, BC Duckworth, LC Cantley and HF Lodish. (1997). Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci USA 94:3016-3021.
61. Muszynski KW, T Ohashi, C Hanson and SK Ruscetti. (1998). Both the polycythemia-and anemia-inducing strains of Friend spleen focus-forming virus induce constitutive activation of the Raf-1/mitogen-activated protein kinase signal transduction pathway. J Virol 72:9119-9125.
62. Abate C, and T Curran. (1990). Encounters with Fos and Jun on the road to AP-1. Semin Cancer Biol 1:19-26.
63. Paul A, S Wilson, CM Belham, CJM Robinson, PH Scott, GW Gould and R Plevin. (1997). Stress-activated protein kinases: activation, regulation and function. Cell Signal 9: 403-410.
64. Foltz IN, and JW Schrader. (1997). Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood 89:3092-3096.
65. Nagata Y, E Nishida and K Todokoro. (1997). Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3. Blood 89:2664-2669.
66. Bergelson S, U Klingmuller, M Socolovsky, JG Hsiao and HF Lodish. (1998). Tyrosine residues within the intracellular domain of the erythropoietin receptor mediate activation of AP-1 transcription factors. J Biol Chem 273:2396-2401.